Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steffen Borrmann

Showing results (11-20 of 111) with videos related to

Pageof 12
Sort By:
The Journal of Infectious Diseases|May 13, 2009
Vaccine-like immunity against malaria by repeated causal-prophylactic treatment of liver-stage Plasmodium parasitesElyzana Dewi Putrianti, Olivier Silvie, Maximilian Kordes, et al.
Antimicrobial Agents and Chemotherapy|February 27, 2008
Effects of Plasmodium falciparum parasite population size and patient age on early and late parasitological outcomes of antimalarial treatment in childrenSteffen Borrmann, Pierre-Blaise Matsiegui, Michel Anoumou Missinou, et al.
The Journal of Infectious Diseases|October 31, 2002
Immune responses induced by repeated treatment do not result in protective immunity to Schistosoma haematobium: interleukin (IL)-5 and IL-10 responsesAnita H J van den Biggelaar, Steffen Borrmann, Peter Kremsner, et al.
Wiener Klinische Wochenschrift|March 28, 2003
Severe malaria in a splenectomised Gabonese womanMartin P Grobusch, Steffen Borrmann, Justin Omva, et al.
Plos Medicine|November 21, 2008
Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malariaSteffen Borrmann, Tim Peto, Robert W Snow, et al.
The American Journal of Tropical Medicine and Hygiene|August 5, 2015
An Economic Evaluation of the Posttreatment Prophylactic Effect of Dihydroartemisinin-Piperaquine Versus Artemether-Lumefantrine for First-Line Treatment of Plasmodium falciparum Malaria Across Different Transmission Settings in AfricaJohannes Pfeil, Steffen Borrmann, Quique Bassat, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|April 28, 2004
Randomized controlled trial of a traditional preparation of Artemisia annua L. (Annual Wormwood) in the treatment of malariaMarkus S Mueller, Nyabuhanga Runyambo, Irmela Wagner, et al.
Vaccine|September 10, 2014
Protection against malaria by immunization with non-attenuated sporozoites under single-dose piperaquine-tetraphosphate chemoprophylaxisJohannes Pfeil, Katharina Jutta Sepp, Kirsten Heiss, et al.
The Journal of Antimicrobial Chemotherapy|October 31, 2002
Evidence for the efficacy of artesunate in asymptomatic Plasmodium malariae infectionsSteffen Borrmann, Nicole Szlezák, Ronald K Binder, et al.
Science Translational Medicine|July 16, 2010
Natural immunization against malaria: causal prophylaxis with antibioticsJohannes Friesen, Olivier Silvie, Elyzana Dewi Putrianti, et al.
Pageof 12

Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
The Journal of Infectious Diseases|May 13, 2009
Vaccine-like immunity against malaria by repeated causal-prophylactic treatment of liver-stage Plasmodium parasitesElyzana Dewi Putrianti, Olivier Silvie, Maximilian Kordes, et al.
Antimicrobial Agents and Chemotherapy|February 27, 2008
Effects of Plasmodium falciparum parasite population size and patient age on early and late parasitological outcomes of antimalarial treatment in childrenSteffen Borrmann, Pierre-Blaise Matsiegui, Michel Anoumou Missinou, et al.
The Journal of Infectious Diseases|October 31, 2002
Immune responses induced by repeated treatment do not result in protective immunity to Schistosoma haematobium: interleukin (IL)-5 and IL-10 responsesAnita H J van den Biggelaar, Steffen Borrmann, Peter Kremsner, et al.
Wiener Klinische Wochenschrift|March 28, 2003
Severe malaria in a splenectomised Gabonese womanMartin P Grobusch, Steffen Borrmann, Justin Omva, et al.
Plos Medicine|November 21, 2008
Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malariaSteffen Borrmann, Tim Peto, Robert W Snow, et al.
The American Journal of Tropical Medicine and Hygiene|August 5, 2015
An Economic Evaluation of the Posttreatment Prophylactic Effect of Dihydroartemisinin-Piperaquine Versus Artemether-Lumefantrine for First-Line Treatment of Plasmodium falciparum Malaria Across Different Transmission Settings in AfricaJohannes Pfeil, Steffen Borrmann, Quique Bassat, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|April 28, 2004
Randomized controlled trial of a traditional preparation of Artemisia annua L. (Annual Wormwood) in the treatment of malariaMarkus S Mueller, Nyabuhanga Runyambo, Irmela Wagner, et al.
Vaccine|September 10, 2014
Protection against malaria by immunization with non-attenuated sporozoites under single-dose piperaquine-tetraphosphate chemoprophylaxisJohannes Pfeil, Katharina Jutta Sepp, Kirsten Heiss, et al.
The Journal of Antimicrobial Chemotherapy|October 31, 2002
Evidence for the efficacy of artesunate in asymptomatic Plasmodium malariae infectionsSteffen Borrmann, Nicole Szlezák, Ronald K Binder, et al.
Science Translational Medicine|July 16, 2010
Natural immunization against malaria: causal prophylaxis with antibioticsJohannes Friesen, Olivier Silvie, Elyzana Dewi Putrianti, et al.
Pageof 12